Teva Pharmaceutical Industries Adds US$389m To Market Cap, But Investors Still Down 47% From Five Years Ago - Simply Wall St News
![Teva Pharmaceutical Industries Limited (NYSE:TEVA) is expected to earn $0.53 per share in the first quarter of 2023. – Best stocks to buy now, Stocks to buy Teva Pharmaceutical Industries Limited (NYSE:TEVA) is expected to earn $0.53 per share in the first quarter of 2023. – Best stocks to buy now, Stocks to buy](https://beststocks.com/wp-content/uploads/2023/02/business-news-today-750x375.jpg)
Teva Pharmaceutical Industries Limited (NYSE:TEVA) is expected to earn $0.53 per share in the first quarter of 2023. – Best stocks to buy now, Stocks to buy
![Teva Pharmaceutical Industries Pharmaceutical industry Teva Pharmaceuticals USA Regulatory affairs NYSE:TEVA, Business, text, people, logo png | PNGWing Teva Pharmaceutical Industries Pharmaceutical industry Teva Pharmaceuticals USA Regulatory affairs NYSE:TEVA, Business, text, people, logo png | PNGWing](https://w7.pngwing.com/pngs/92/378/png-transparent-teva-pharmaceutical-industries-pharmaceutical-industry-teva-pharmaceuticals-usa-regulatory-affairs-nyse-teva-business-text-people-logo.png)